Cumulative survival rates of patients with unresectable hepatocellular carcinoma (HCC) receiving lenvatinib and factors associated with patient outcome.
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接：
官方服务：
资源简介：
Cumulative survival rates of patients with unresectable hepatocellular carcinoma (HCC) receiving lenvatinib and factors associated with patient outcome.
创建时间：
2020-04-10
